Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Gout: HELP
Michael Gillen
Based on 2 articles published since 2008
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 2 published articles on Gout from 2008 through 2019, it is not possible for Expertscape to reliably rate Michael Gillen's expertise on this topic.

Uncounted papers?
Work Locations
Details
Most likely:    AstraZeneca      
2018
  • SOUSEIKAI PS Clinic, Fukuoka, Japan. · Ardea Biosciences, Inc., San Diego, CA, USA. · AstraZeneca LP, Gaithersburg, MD, USA. · AstraZeneca K.K., Osaka, Japan. · Pubmed 29868853
  • Preclinical and Clinical DMPK (C.A.L., C.Y.,V.S., Z.S.), Bioanalytical (D.M.W.), Biology (T.M.O.), Chemistry (J.-L.G.), and Clinical Development (J.H.) Ardea Biosciences, Inc., San Diego, California; and Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology (M.G.) AstraZeneca LP, Gaithersburg, Maryland · Preclinical and Clinical DMPK (C.A.L., C.Y.,V.S., Z.S.), Bioanalytical (D.M.W.), Biology (T.M.O.), Chemistry (J.-L.G.), and Clinical Development (J.H.) Ardea Biosciences, Inc., San Diego, California; and Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology (M.G.) AstraZeneca LP, Gaithersburg, Maryland. · Pubmed 29490903
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Michael Gillen in 2008-2019 about Gout:

  • Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study. 2018
  • Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in Humans. 2018
Show List of Full Article Records
Google Searches

Learn more about Michael Gillen using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
AstraZeneca
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
AstraZeneca
2018
  • SOUSEIKAI PS Clinic, Fukuoka, Japan. · Ardea Biosciences, Inc., San Diego, CA, USA. · AstraZeneca LP, Gaithersburg, MD, USA. · AstraZeneca K.K., Osaka, Japan. · Pubmed 29868853
  • Preclinical and Clinical DMPK (C.A.L., C.Y.,V.S., Z.S.), Bioanalytical (D.M.W.), Biology (T.M.O.), Chemistry (J.-L.G.), and Clinical Development (J.H.) Ardea Biosciences, Inc., San Diego, California; and Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology (M.G.) AstraZeneca LP, Gaithersburg, Maryland · Preclinical and Clinical DMPK (C.A.L., C.Y.,V.S., Z.S.), Bioanalytical (D.M.W.), Biology (T.M.O.), Chemistry (J.-L.G.), and Clinical Development (J.H.) Ardea Biosciences, Inc., San Diego, California; and Early Clinical Development, IMED Biotech Unit, Quantitative Clinical Pharmacology (M.G.) AstraZeneca LP, Gaithersburg, Maryland. · Pubmed 29490903
Yearly article counts 020000000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.